EXEL - Exelixis, Inc. - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXEL (939767)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
77 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S22-1-1+2+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-11-29
EXELScangos George ADirS - Sale$20.84-55,0001,480,576-4%-$1,146,400
D
2018-12-03
EXELSchwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$21.02-13,499331,018-4%-$283,749
M
2018-11-28
EXELHessekiel JeffreyEVP, GCS - Sale$19.25-14,818234,437-6%-$285,290
2018-11-30
EXELSenner Christopher J.EVP, CFOS - Sale$19.70-8,791149,300-6%-$173,183
D
2018-11-15
EXELMorrissey MichaelPres, CEOS - Sale+OE$17.22-25,000301,352-8%-$430,500
2018-11-07
EXELHaley Patrick J.SVP, CommercialS - Sale$17.32-20,000138,739-13%-$346,400
D
2018-11-01
EXELSchwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$14.16-12,000342,793-3%-$169,920
2018-11-01
EXELScangos George ADirS - Sale$14.66-25,0001,535,576-2%-$366,400
D
2018-11-02
EXELMorrissey MichaelPres, CEOS - Sale+OE$17.57-37,499318,705-11%-$658,964
2018-10-01
EXELScangos George ADirS - Sale$17.86-25,0001,560,576-2%-$446,500
D
2018-10-01
EXELMorrissey MichaelPres, CEOS - Sale+OE$17.82-12,501318,705-4%-$222,768
D
2018-10-01
EXELSchwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$17.77-12,000342,793-3%-$213,240
2018-09-24
EXELScangos George ADirS - Sale$16.85-25,0001,585,576-2%-$421,250
D
2018-09-04
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$18.53-22,500342,793-6%-$416,925
D
2018-08-20
EXELMorrissey MichaelPres, CEOS - Sale+OE$17.82-90,000318,705-22%-$1,604,216
D
2018-08-15
EXELMarchesi Vincent TDirS - Sale+OE$19.50-40,000133,850-23%-$780,000
DM
2018-08-07
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.04-234,267318,705-42%-$4,928,523
2018-08-06
EXELHaley Patrick J.SVP, CommercialS - Sale$20.92-2,361158,735-1%-$49,392
D
2018-08-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$20.56-22,500292,793-7%-$462,600
D
2018-07-16
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.13-90,000318,705-22%-$1,901,700
D
2018-07-02
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$21.20-22,500292,793-7%-$477,000
D
2018-06-25
EXELMorrissey MichaelPres, CEOS - Sale+OE$19.62-90,000318,705-22%-$1,765,800
2018-05-31
EXELHessekiel JeffreyEVP, GCS - Sale$20.71-65,000255,067-20%-$1,346,150
D
2018-05-30
EXELFeldbaum Carl BDirS - Sale+OE$20.60-34,26215,221-69%-$705,797
D
2018-06-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$20.80-22,500292,793-7%-$468,000
D
2018-05-22
EXELWillsey LanceDirS - Sale+OE$21.40-50,000418,273-11%-$1,070,000
D
2018-05-24
EXELMorrissey MichaelPres, CEOS - Sale+OE$20.55-90,000318,705-22%-$1,849,500
2018-05-18
EXELHaley Patrick J.SVP, CommercialS - Sale$21.61-3,663160,967-2%-$79,157
D
2018-05-11
EXELMarchesi Vincent TDirS - Sale+OE$19.03-15,000125,913-11%-$285,450
D
2018-05-09
EXELCohen CharlesDirS - Sale+OE$21.42-15,000248,180-6%-$321,300
D
2018-05-07
EXELPapadopoulos SteliosDirS - Sale+OE$22.15-15,0001,034,314-1%-$332,250
2018-05-04
EXELHessekiel JeffreyEVP, GCS - Sale$22.36-20,000320,067-6%-$447,200
DM
2018-05-04
EXELHaley Patrick J.SVP, CommercialS - Sale+OE$22.17-27,549164,630-14%-$610,847
D
2018-05-03
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.09-22,500292,793-7%-$519,417
D
2018-04-16
EXELWyszomierski Jack LDirS - Sale+OE$20.25-14,95993,844-14%-$302,920
D
2018-04-16
EXELGarber Alan MDirS - Sale+OE$20.25-15,00061,329-20%-$303,750
D
2018-04-11
EXELMorrissey MichaelPres, CEOS - Sale+OE$20.78-90,000318,604-22%-$1,870,200
D
2018-03-05
EXELFeldbaum Carl BDirS - Sale+OE$23.88-11,00034,733-24%-$262,680
D
2018-03-05
EXELCohen CharlesDirS - Sale+OE$24.23-15,000248,180-6%-$363,450
D
2018-03-06
EXELMarchesi Vincent TDirS - Sale+OE$24.73-15,000125,913-11%-$370,950
D
2018-03-02
EXELPapadopoulos SteliosDirS - Sale+OE$24.05-15,0001,034,314-1%-$360,750
D
2018-03-02
EXELWillsey LanceDirS - Sale+OE$23.91-30,000468,273-6%-$717,300
D
2018-02-28
EXELHaley Patrick J.SVP, CommercialS - Sale+OE$27.13-45,029147,130-23%-$1,221,637
D
2018-02-28
EXELPoste GeorgeDirS - Sale+OE$26.26-15,00083,398-15%-$393,900
DM
2018-01-08
EXELGarber Alan MDirS - Sale+OE$30.30-15,00061,329-20%-$454,515
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-22
EXELPapadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
M
2017-09-18
EXELPapadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-14
EXELHaley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
M
2017-09-12
EXELWillsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-05-30
EXELHaley Patrick J.SVP, CommercialS - Sale$18.46-5,000135,686-4%-$92,300
D
2017-05-15
EXELFeldbaum Carl BDirS - Sale+OE$21.58-32,98834,733-49%-$711,831
DM
2017-05-08
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.87-211,300249,716-46%-$4,622,159-2
DM
2017-05-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.24-259,149249,668-51%-$5,762,838-10
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.01-89,910184,690-33%-$2,068,519-2-3
D
2017-04-03
EXELMarchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5+6
D
2017-03-31
EXELWyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6+7
2017-03-27
EXELHessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
D
2017-03-22
EXELHessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
D
2017-03-20
EXELFeldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-15
EXELWillsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-13
EXELCohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
D
2017-03-10
EXELMarchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELHessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELHaley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-03
EXELSenner Christopher J.EVP, CFOS - Sale$22.80-11,000102,181-10%-$250,800-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.19-45,00089,728-33%-$998,550-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirS - Sale+OE$22.53-76,25077,555-50%-$1,718,185-2-5-6
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$18.65-70,00089,680-44%-$1,305,500-1+12+13
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$14.65-70,00089,624-44%-$1,025,636+2+21+34
D
2016-12-16
EXELFeldbaum Carl BDirS - Sale+OE$17.03-25,00048,721-34%-$425,750-3-11+7
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top